When combined with a comprehensive weight management plan, GLP-1 medications provide a reliable and holistic approach to achieving lasting weight loss and improved health
The glucagon receptor component is hypothesised to increase energy expenditure and promote fat breakdown (lipolysis), potentially contributing to the substantial weight loss observed in early-phase trials
In addition, tirzepatide, even at the lowest maintenance dose of 5 mg, can reduce body weight to a greater extent compared with GLP-1 RAs including subcutaneous semaglutide which, in turn, has been shown to be superior to other glucose-lowering agents [28]
Talk to a licensed healthcare provider before starting any weight-loss medication
[DOI] [PubMed] [Google Scholar] 110.Lien F., Berthier A., Bouchaert E., Gheeraert C., Alexandre J., Porez G., Prawitt J., Dehondt H., Ploton M., Colin S., et al
Pederson, R